Related Experiment Video
Updated: Aug 8, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Y-box protein-1 is the crucial mediator of antifibrotic interferon-gamma effects
Steven Dooley1, Harun M Said, Axel M Gressner
1Institute of Clinical Chemistry and Pathobiochemistry, University Hospital Aachen, RWTH-Aachen, Germany. steven.dooley@med.ma.uni-heidelberg.de
Abstract:
Y-box protein-1 (YB-1) is a known negative regulator of collagen (Col) expression by two different mechanisms, acting directly through binding to an interferon-gamma response element within the col1A2 promoter and/or by physically interacting with p300/Smad3, thereby abrogating the stimulatory effect of transforming growth factor-beta (TGF-beta). Here, we report that YB-1 activation via the Jak1 signaling pathway is required and sufficient to confer interferon-gamma-dependent activation of the smad7 gene. By binding to a bona fide recognition site within the smad7 promoter, YB-1 up-regulates smad7 transcription, which was additively enhanced by autoinhibitory TGF-beta signaling. Importantly, the anti-TGF-beta effect was not only supplied by induced Smad7 expression but was recapitulated in the context of the col1A2 promoter, where YB-1 overexpression abolished the trans-stimulatory TGF-beta effect in a dominant fashion. In conclusion, YB-1 is the main target of interferon-gamma signaling via Jak1 that exerts antifibrotic action by both interference with TGF-beta signaling and direct down-regulation of collagen expression.
Insights
Y-box protein-1 (YB-1) activates Smad7 via Jak1 signaling, reducing collagen expression. This interferon-gamma-mediated pathway offers an antifibrotic mechanism by interfering with TGF-beta signaling.
Area of Science:
- Molecular Biology
- Immunology
- Cell Signaling
Background:
- Y-box protein-1 (YB-1) is recognized as a negative regulator of collagen (Col) expression.
- YB-1 exerts its regulatory function through direct promoter binding or interaction with p300/Smad3, inhibiting transforming growth factor-beta (TGF-beta) signaling.
Purpose of the Study:
- To investigate the role of YB-1 in interferon-gamma (IFN-γ)-dependent gene regulation.
- To elucidate the mechanism by which YB-1 mediates antifibrotic effects.
Main Methods:
- Analysis of YB-1 activation through the Jak1 signaling pathway.
- Chromatin immunoprecipitation assays to assess YB-1 binding to the smad7 promoter.
- Reporter gene assays to quantify gene expression.
- Overexpression studies to evaluate the impact on TGF-beta signaling and collagen expression.
Main Results:
- YB-1 activation via Jak1 signaling is essential and sufficient for IFN-γ-dependent activation of the smad7 gene.
- YB-1 binds to the smad7 promoter, up-regulating its transcription, an effect additively enhanced by TGF-beta signaling.
- YB-1 overexpression inhibits TGF-beta-induced collagen expression, demonstrating an anti-TGF-beta effect independent of Smad7 induction.
Conclusions:
- YB-1 is a key mediator of IFN-γ signaling through Jak1, exhibiting antifibrotic properties.
- YB-1 exerts antifibrotic action by both inhibiting TGF-beta signaling and directly down-regulating collagen expression.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The JAK-STAT Signaling Pathway
TGF - β Signaling Pathway
Intracellular Signaling Affects Focal Adhesions
Some...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inhibitors of Viral Protein Synthesis

